Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Holt

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Transplantation|January 27, 2004
Patient management by cyclosporine C2 monitoringAnamarija Jorga, Atholl Johnston, David W Holt
Transplant Immunology|August 16, 2002
How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipientsJochen Klupp, David W Holt, Teun van Gelder
The Journal of Extra-Corporeal Technology|January 7, 2022
Alternative Input for Perfusion Management Devices: Voice Recognition for Data Input and the Effects on Charting and Perioperative Calculation UseKara Lung, Brandi Brummer, Scott Sanderson, et al.
Expert Opinion on Pharmacotherapy|December 1, 2005
Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?Iain A M MacPhee, Salim Fredericks, David W Holt
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 25, 2003
The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administrationSalim Fredericks, David W Holt, Iain A M MacPhee
Pharmacogenomics|May 10, 2008
Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patientsNasirul J Ekbal, David W Holt, Iain Am Macphee
The Medical Journal of Malaysia|July 25, 2012
Changes in salivary immunoglobulin A (IgA) following match-play and training among English premiership footballersSalim Fredericks, Lynn Fitzgerald, Graham Shaw, et al.
The Journal of Extra-Corporeal Technology|August 19, 2008
Does zero balance ultrafiltration decrease the incidence of post-cardiopulmonary bypass atrial fibrillation?Mark T Lucas, John Limoli, Joseph Schlut, et al.
Expert Opinion on Pharmacotherapy|August 24, 2007
Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantationFu Liang Ng, David W Holt, Iain A M MacPhee
Perfusion|July 18, 2007
Quality assessment of platelet rich plasma during anti-platelet therapyChad W Smith, Robert S Binford, David W Holt, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Transplantation|January 27, 2004
Patient management by cyclosporine C2 monitoringAnamarija Jorga, Atholl Johnston, David W Holt
Transplant Immunology|August 16, 2002
How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipientsJochen Klupp, David W Holt, Teun van Gelder
The Journal of Extra-Corporeal Technology|January 7, 2022
Alternative Input for Perfusion Management Devices: Voice Recognition for Data Input and the Effects on Charting and Perioperative Calculation UseKara Lung, Brandi Brummer, Scott Sanderson, et al.
Expert Opinion on Pharmacotherapy|December 1, 2005
Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?Iain A M MacPhee, Salim Fredericks, David W Holt
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 25, 2003
The pharmacogenetics of immunosuppression for organ transplantation: a route to individualization of drug administrationSalim Fredericks, David W Holt, Iain A M MacPhee
Pharmacogenomics|May 10, 2008
Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patientsNasirul J Ekbal, David W Holt, Iain Am Macphee
The Medical Journal of Malaysia|July 25, 2012
Changes in salivary immunoglobulin A (IgA) following match-play and training among English premiership footballersSalim Fredericks, Lynn Fitzgerald, Graham Shaw, et al.
The Journal of Extra-Corporeal Technology|August 19, 2008
Does zero balance ultrafiltration decrease the incidence of post-cardiopulmonary bypass atrial fibrillation?Mark T Lucas, John Limoli, Joseph Schlut, et al.
Expert Opinion on Pharmacotherapy|August 24, 2007
Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantationFu Liang Ng, David W Holt, Iain A M MacPhee
Perfusion|July 18, 2007
Quality assessment of platelet rich plasma during anti-platelet therapyChad W Smith, Robert S Binford, David W Holt, et al.
Pageof 11